Dividend Distribution - The company plans to distribute a cash dividend of 2.78 CNY per 10 shares, totaling approximately 30.02 million CNY, which accounts for 40.97% of the net profit attributable to shareholders for the year 2019[6]. - The company does not plan to increase capital reserves or issue bonus shares for the 2019 profit distribution[6]. - The board of directors has approved the profit distribution plan, pending approval from the shareholders' meeting[6]. - The company emphasizes a stable and scientific return mechanism for investors, adhering to relevant regulations and ensuring transparency in the decision-making process for profit distribution[131]. - The company plans to maintain a cash dividend ratio of at least 80% if in a mature stage without significant capital expenditure, and at least 40% if there are major capital expenditures[133]. - The company has established a profit distribution policy ensuring that cash dividends will not be less than 10% of the distributable profits for the year, with a cumulative cash distribution of at least 30% of the average annual distributable profits over the last three years[158]. Financial Performance - The company's operating revenue for 2019 was RMB 457,494,623.49, representing a year-on-year increase of 4.93% compared to RMB 436,017,584.47 in 2018[22]. - The net profit attributable to shareholders of the listed company was RMB 73,281,872.81, up 4.31% from RMB 70,256,586.67 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was RMB 58,813,624.80, a decrease of 6.34% from RMB 62,793,611.74 in 2018[22]. - The company's total assets increased by 134.12% to RMB 1,140,851,571.58 at the end of 2019, compared to RMB 487,291,332.19 at the end of 2018[22]. - The net assets attributable to shareholders of the listed company rose by 378.35% to RMB 875,279,015.50 at the end of 2019, compared to RMB 182,978,704.18 at the end of 2018[22]. - The basic earnings per share for 2019 was RMB 0.79, down 9.20% from RMB 0.87 in 2018[23]. - The weighted average return on net assets was 15.33%, a decrease of 32.06 percentage points from 47.39% in 2018[23]. - The net cash flow from operating activities was negative at RMB -11,137,846.91, a significant decline of 118.51% compared to RMB 60,172,412.22 in 2018[22]. Research and Development - The R&D expenditure accounted for 6.31% of operating revenue, an increase of 1.81 percentage points from 4.50% in 2018[23]. - The company has invested significantly in R&D for new products and technologies, maintaining industry-leading technical levels[49]. - The company applied for 12 new invention patents and obtained 41 patent authorizations in 2019[53]. - The company has developed 14 core technologies and has been granted 78 patents and 29 software copyrights, showcasing its innovation capabilities[65]. - The company has established a research center for precision high-speed cam mechanisms and automotive electronic intelligent manufacturing equipment in Jiangsu Province, enhancing its technological advantages[64]. - The company has a workforce of 402 R&D and technical personnel, accounting for 50.5% of total employees, emphasizing its commitment to talent development[67]. Market Expansion and Strategy - The company is focused on expanding its market presence and enhancing its product offerings through technological advancements in AI and IIoT[20]. - The company is actively expanding into high-growth sectors such as healthcare, new energy batteries, and industrial interconnect systems[99]. - The company plans to collaborate with major global clients like Medtronic and 3M to expand its market share in the medical health sector[124]. - The company has established a modular and unitized production model, allowing for customized manufacturing based on client needs[35]. - The company has accumulated a stable partnership with numerous global clients, leveraging its strong R&D capabilities and technical innovation[31]. Operational Risks and Compliance - The company has disclosed various operational risks in the report, urging investors to pay attention to these factors[4]. - The company emphasizes that forward-looking statements regarding future plans and strategies do not constitute substantive commitments to investors[7]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties[7]. - There are no violations of decision-making procedures regarding external guarantees[7]. - The company has not reported any major changes in its internal control audit arrangements during the reporting period[163]. Shareholder and Governance - The independent directors will actively participate in the decision-making process regarding profit distribution, ensuring the protection of minority shareholders' rights[136]. - The company has committed to disclose any changes in shareholding by its directors and senior management[140]. - The company has established a mechanism to adjust share prices in accordance with regulatory requirements during the lock-up period[141]. - The company has committed to report any breaches of share lock-up agreements within 20 days[141]. - The company will not seek improper benefits that could harm the rights of other shareholders[143]. Environmental and Safety Standards - The company has a comprehensive safety management system in place, including regular safety inspections and employee training[182]. - The company’s production processes generate minimal pollutants, primarily consisting of small amounts of waste gas, wastewater, and noise[184]. - The company has a waste gas treatment capacity that matches its production capacity, ensuring compliance with environmental standards[185]. - The company’s noise levels during production are maintained within acceptable limits, with measures in place to mitigate sound pollution[185]. Legal and Regulatory Compliance - The company reported no direct or indirect competition with its own business as of the date of the commitment letter[143]. - The company has not disclosed any significant related party transactions that would affect its financial position[164]. - There were no significant lawsuits or arbitration matters during the reporting period, indicating a stable legal environment for the company[163]. - The company guarantees that there will be no fraudulent issuance during the IPO process[154].

Financial Performance - Operating revenue for the first nine months rose by 6.04% to CNY 255,573,039.26 compared to the same period last year[5] - Net profit attributable to shareholders increased by 25.50% to CNY 35,535,863.00 compared to the same period last year[5] - Net profit attributable to shareholders increased by 42.05% to RMB 117,485,292.89 from RMB 82,705,913.10, driven by higher revenues[13] - Net profit for the first three quarters of 2019 reached CNY 74,764,231.80, up from CNY 40,580,919.04 in the same period of 2018, indicating an increase of 84.2%[23] - Net profit for Q3 2019 was CNY 26.70 million, down from CNY 27.10 million in Q3 2018, representing a decline of 1.5%[28] - Total profit for Q3 2019 was CNY 30.53 million, down from CNY 31.58 million in Q3 2018, a decrease of 3.3%[27] Assets and Liabilities - Total assets increased by 150.17% to CNY 1,219,078,838.75 compared to the end of the previous year[5] - The company's total assets amounted to CNY 1,219,078,838.75, a significant increase from CNY 487,291,332.19 in the previous year[18] - Total current assets as of September 30, 2019, reached CNY 1,079,309,705.20, compared to CNY 373,834,647.40 at the end of 2018, indicating a substantial growth[16] - The company's total liabilities increased to CNY 377,343,987.89, up from CNY 300,089,360.47, indicating a rise in financial obligations[18] - Total liabilities amounted to CNY 259,559,867.73, compared to CNY 169,065,996.86 at the end of 2018, an increase of 53.6%[22] Shareholder Information - Net assets attributable to shareholders increased by 358.32% to CNY 838,635,723.08 compared to the end of the previous year[5] - The total equity attributable to shareholders reached CNY 838,635,723.08, compared to CNY 182,978,704.18 in the previous year, showing strong growth in shareholder value[18] - The total number of shareholders reached 11,436 by the end of the reporting period[9] - The largest shareholder, Suzhou Hanchuan Investment Management Co., Ltd., holds 33.79% of the shares[9] Cash Flow - Net cash flow from operating activities decreased by 463.18% to -CNY 51,849,366.09 compared to the same period last year[5] - Cash flow from operating activities for the first nine months of 2019 was CNY -51,849,366.09, compared to CNY 14,276,554.71 in the same period of 2018, showing a significant decrease[34] - Total cash inflow from financing activities in the first nine months of 2019 was CNY 721,566,706.56, a substantial increase from CNY 41,660,576.38 in the previous year[34] - The net increase in cash and cash equivalents for the first nine months of 2019 was CNY 581,791,543.94, compared to a decrease of CNY 1,210,173.90 in the same period of 2018[34] - Cash and cash equivalents at the end of the period totaled 627,608,395.30 RMB, up from 19,312,209.89 RMB at the end of the same period last year[37] Expenses - Management expenses rose by 47.38% to RMB 26,737,524.79 from RMB 18,141,836.54, reflecting increased scale and infrastructure investments[13] - Cash paid for operating activities increased by 40.66% to CNY 39,020,230.92, primarily due to increased employee travel and logistics costs[14] - The company paid CNY 94,892,334.74 to employees in the first nine months of 2019, an increase from CNY 68,804,908.55 in the previous year[34] - The company's operating expenses for Q3 2019 included CNY 3.19 million in sales expenses, up from CNY 1.85 million in Q3 2018, an increase of 72.4%[29] Government Subsidies - Government subsidies recognized in the current period amounted to CNY 5,117,728.76[7] - The company received government subsidies amounting to RMB 13,104,303.80, a 54.33% increase from RMB 8,490,896.55 in the previous year[13] Research and Development - Research and development expenses for Q3 2019 were CNY 5,400,528.05, slightly up from CNY 5,367,903.74 in Q3 2018, showing a marginal increase of 0.6%[25] - Research and development expenses for Q3 2019 were CNY 7.34 million, significantly higher than CNY 1.63 million in Q3 2018, indicating an increase of 348.5%[29] Market and Product Development - The company has not disclosed any new product developments or market expansion strategies in this report[12] - The company has plans for market expansion and new product development, although specific figures were not disclosed in the report[24]